Omicron Covid Variant: One Pharmaceutical Company Claims It Already Has a ‘Vaccine’ in Testing for It

Novavax said on Friday it has “started working on a version of its COVID-19 vaccine to target the variant detected in South Africa.” “Novavax would have the shot ready for testing and manufacturing in the next few weeks,” Reuters reported. “The company’s COVID-19 shot contains an actual version of the virus’ spike protein that cannot cause disease but can trigger the immune system,” Reuters noted. “The vaccine developer said it had started developing a spike protein specifically based on the known genetic sequence of the variant, B.1.1.529.” “The initial work will take a few weeks,” a company spokesperson said. “Shares…